During the past decade, Methodist Children's Hospital of South Texas conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 78 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 30 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Children's Hospital of South Texas" #1 sponsor was "Children's Oncology Group" with 121 trials, followed by "National Cancer Institute (NCI)" with 47 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Aerogen Pharma Limited" with 1 trials sponsored and "Center for International Blood and Marrow Transplant Research" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Children's Hospital of South Texas" #1 collaborator was "National Cancer Institute (NCI)" with 122 trials as a collaborator, "Children's Oncology Group" with 10 trials as a collaborator, "Primary Immune Deficiency Treatment Consortium (PIDTC)" with 3 trials as a collaborator, "National Center for Advancing Translational Sciences (NCATS)" with 2 trials as a collaborator and "Boston University" with 1 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Children's Hospital of South Texas" are "Recurrent Neuroblastoma" (20 trials), "Refractory Neuroblastoma" (14 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials), "Acute Lymphoblastic Leukemia" (13 trials) and "Recurrent Malignant Solid Neoplasm" (13 trials). Many other conditions were trialed in "Methodist Children's Hospital of South Texas" in a lesser frequency.

Most popular intervention types in "Methodist Children's Hospital of South Texas" are "Drug" (143 trials), "Other" (99 trials), "Procedure" (71 trials), "Biological" (64 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Cyclophosphamide" (41 trials), "Vincristine Sulfate" (38 trials), "Etoposide" (29 trials) and "Doxorubicin Hydrochloride" (28 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Children's Hospital of South Texas" are 182 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist Children's Hospital of South Texas". undefined are not yet recruiting, 36 are recruiting, 60 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 77 completed trials in Methodist Children's Hospital of South Texas, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Children's Hospital of South Texas, 8 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".